Plasma exchange as a cost-effective option for treating Guillain-Barré syndrome
- PMID: 28450897
- PMCID: PMC5400150
- DOI: 10.1177/1756285616659978
Plasma exchange as a cost-effective option for treating Guillain-Barré syndrome
Conflict of interest statement
Conflict of interest statement: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Buenz has been employed by Talecris (Grifols) and Terumo BCT, manufacturers of IVIG and PLEX, respectively. He has served as a Medical Advisor for Terumo BCT.
Similar articles
-
Treatment of Guillain-Barré syndrome: a cost-effectiveness analysis.J Clin Apher. 1999;14(3):107-13. doi: 10.1002/(sici)1098-1101(1999)14:3<107::aid-jca1>3.0.co;2-3. J Clin Apher. 1999. PMID: 10540364 Review.
-
Cost-minimization analysis in the Indian subcontinent for treating Guillain Barre Syndrome patients with therapeutic plasma exchange as compared to intravenous immunoglobulin.J Clin Apher. 2018 Dec;33(6):631-637. doi: 10.1002/jca.21646. Epub 2018 Oct 17. J Clin Apher. 2018. PMID: 30329175 Clinical Trial.
-
Guillain-Barre syndrome in a 7-month-old boy successfully applied plasma exchange.Transfus Apher Sci. 2016 Feb;54(1):139-43. doi: 10.1016/j.transci.2016.01.001. Epub 2016 Jan 12. Transfus Apher Sci. 2016. PMID: 26803348
-
Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barré syndrome. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.Intensive Care Med. 2000 Aug;26(8):1094-100. doi: 10.1007/s001340051323. Intensive Care Med. 2000. PMID: 11030166 Clinical Trial.
-
Therapeutic issues in Guillain-Barré syndrome.Expert Rev Neurother. 2023 Jun;23(6):549-557. doi: 10.1080/14737175.2023.2212163. Epub 2023 May 9. Expert Rev Neurother. 2023. PMID: 37151048 Review.
Cited by
-
Intravenous immunoglobulin and plasma exchange prescribing patterns for Guillain-Barre Syndrome in the United States-2001 to 2018.Muscle Nerve. 2024 Dec;70(6):1192-1199. doi: 10.1002/mus.28265. Epub 2024 Sep 26. Muscle Nerve. 2024. PMID: 39324188
References
-
- Furlan J.C., Barth D., Barnett C., Bril V. (2016) Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis. Muscle Nerve 53(6): 872–876. Epub ahead of print 26 November 2015. doi: 10.1002/mus.24960. PubMed PMID: 26521889. - DOI - PubMed
-
- Jones P., Sopina E., Ashton T. (2014) Resource Implications of a national health target: the New Zealand experience of a shorter stays in emergency departments target. Emerg Med Australas 26: 579–584. - PubMed
-
- Raphael J., Chevret S., Hughes R., Annane D. (2012) Plasma exchange for Guillain–Barre syndrome. Cochrane Database Syst Rev 7: CD001798. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources